KalVista Pharmaceuticals, Inc. (KALV)

KalVista Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is May - April.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 31, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021	Apr 30, 2020
Cash & Equivalents	167.29	31.79	56.24	30.73	50.59	15.79
Short-Term Investments	85.92	178.61	93.14	135.47	198.34	51.93
Cash & Short-Term Investments	253.2	210.4	149.38	166.2	248.93	67.71
Cash Growth	234.99%	40.85%	-10.12%	-33.23%	267.62%	-32.83%
Other Receivables	9.4	10.87	18.64	16.81	11.72	16.53
Receivables	9.4	10.87	18.64	16.81	11.72	16.53
Prepaid Expenses	4.75	4.42	4.31	10.64	3.62	4.46
Total Current Assets	267.36	225.69	172.33	193.65	264.26	88.7
Property, Plant & Equipment	7.25	9.15	10.77	10.04	7.55	3.66
Other Long-Term Assets	1.39	0.57	0.11	0.19	0.2	0.18
Total Assets	275.99	235.4	183.2	203.88	272.01	92.53
Accounts Payable	5.86	9.11	4.82	3.64	1.98	1.68
Accrued Expenses	18.32	12.4	9.13	6.96	6.93	5.46
Current Portion of Leases	1.44	1.3	1.09	0.98	0.86	0.59
Total Current Liabilities	25.62	22.81	15.03	11.58	9.77	7.72
Long-Term Leases	4.34	6.02	7.15	7.21	5.05	1.06
Total Liabilities	130.87	28.82	22.18	18.79	14.82	8.78
Common Stock	0.05	0.04	0.03	0.03	0.02	0.02
Additional Paid-In Capital	748.23	679.75	507.13	439.1	426.44	207.21
Retained Earnings	-600.95	-469.73	-343.08	-250.18	-167.84	-121.59
Comprehensive Income & Other	-2.21	-3.49	-3.06	-3.86	-1.43	-1.88
Total Common Equity	145.13	206.58	161.03	185.09	257.19	83.75
Shareholders' Equity	145.13	206.58	161.03	185.09	257.19	83.75
Total Liabilities & Equity	275.99	235.4	183.2	203.88	272.01	92.53
Total Debt	5.78	7.32	8.23	8.19	5.91	1.65
Net Cash (Debt)	247.42	203.08	141.14	158.01	243.02	66.07
Net Cash Growth	263.10%	43.89%	-10.68%	-34.98%	267.83%	-34.43%
Net Cash Per Share	5.24	5.52	5.06	6.46	12.73	3.72
Filing Date Shares Outstanding	49.72	42.74	34.23	24.57	24.44	17.85
Total Common Shares Outstanding	49.49	42.52	34.17	24.55	24.42	17.85
Working Capital	241.74	202.88	157.29	182.07	254.49	80.98
Book Value Per Share	2.93	4.86	4.71	7.54	10.53	4.69
Tangible Book Value	145.13	206.58	161.03	185.09	257.19	83.75
Tangible Book Value Per Share	2.93	4.86	4.71	7.54	10.53	4.69
Machinery	-	3.08	3.05	2.6	2.01	1.76
Leasehold Improvements	-	2.86	2.86	2	1.87	1.65

Updated Mar 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q